EPISODE · Jul 15, 2022 · 13 MIN
MPR Weekly Dose 124 — Novavax Vaccine Gains EUA; Comirnaty Adolescent Approval; OTC Switch for Contraceptive; Nasal Spray Available OTC; Dupilumab for Pediatric EoE
from MPR Weekly Dose
Novavax Emergency Use authorization; the Pfizer-BioNTech vaccine gets approval in adolescents; submission for oral contraceptive to be switched to over the counter; Astepro nasal spray gets over-the-counter approval; and Dupixent shows benefits in pediatric patients with eosinophilic esophagitis.
Embed this episode
Ready to play
MPR Weekly Dose 124 — Novavax Vaccine Gains EUA; Comirnaty Adolescent Approval; OTC Switch for Contraceptive; Nasal Spray Available OTC; Dupilumab for Pediatric EoE
0:00
13:36
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of MPR Weekly Dose?
This episode is 13 minutes long.
When was this MPR Weekly Dose episode published?
This episode was published on July 15, 2022.
Can I download this MPR Weekly Dose episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!